Treatment options for inflammatory bowel disease (IBD) are evolving as knowledge of the condition is increasing. In the future, physicians may be able to offer therapy tailored to individual patients. This Learning Zone describes the background behind such advances.
The IBD Learning Zone contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs. It also seeks to explain the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways – inhibition of which are being investigated as potential therapeutic targets for clinical management.
Discover how Crohn's disease develops and presents itself. How does it differ from ulcerative colitis?
Learn about ulcerative colitis, a condition in which the colon becomes inflamed. How does it differ from Crohn's disease?
Explore the current and potential future inflammatory targets exploited in the treatment of IBD.
Check key events and view conference and congress information, providing an opportunity to discover the latest procedures, techniques and guidelines.
View a number of resources from recent congress and symposia to help ensure that everyone can benefit from shared insights.
Read highlights of some of the most recent peer-reviewed publications, updated each month, that discuss the management of Crohn’s disease and ulcerative colitis.